Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States.

Pharmacoepidemiology and Drug Safety
Leah J McGrathM Alan Brookhart

Abstract

In contrast to randomized clinical trials, comparative safety and effectiveness assessments of osteoporosis medications in clinical practice may be subject to confounding by indication. We used negative control outcomes to detect residual confounding when comparing osteoporosis medications. Using MarketScan Commercial and Supplemental claims, we identified women aged ≥55 years who initiated an oral bisphosphonate (BP) (risedronate, alendronate, or ibandronate), denosumab (an injected biologic), or intravenous zoledronic acid (ZA) from October 1, 2010 to September 30, 2015. Women with Paget's disease or cancer were excluded. We compared individual oral BPs to each other, denosumab to ZA, denosumab to oral BPs, and ZA to oral BPs, with respect to 11 negative control outcomes identified by subject matter experts. We estimated the 12-month cumulative risk difference (RD) using inverse probability of treatment and censoring weights. Among 148 587 women, most initiated alendronate (57%), followed by ibandronate (12%), ZA (11%), risedronate (10%), and denosumab (10%). Compared with denosumab, patients initiating ZA had similar risks of all negative control outcomes. Compared with oral BPs, patients initiating denosumab had a higher ri...Continue Reading

References

Mar 1, 1992·Epidemiology·J M Robins, S Greenland
Dec 22, 2005·International Journal of Epidemiology·Lisa A JacksonNoel S Weiss
Dec 2, 2006·Research in Social & Administrative Pharmacy : RSAP·Francis S LoboJon C Schommer
Apr 8, 2009·Circulation·Colin R DormuthM Alan Brookhart
Oct 24, 2013·Current Opinion in Endocrinology, Diabetes, and Obesity·Dima L Diab, Nelson B Watts
Dec 24, 2013·American Journal of Epidemiology·Eric Tchetgen Tchetgen
Mar 14, 2018·Proceedings of the National Academy of Sciences of the United States of America·Martijn J SchuemieMarc A Suchard
Aug 8, 2018·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Martijn J SchuemieMarc A Suchard
Oct 6, 2018·Journal of the American Geriatrics Society·Kandice A KapinosRichard Barron
Jan 19, 2019·Journal of Internal Medicine·Mattias Lorentzon
Mar 26, 2019·The Journal of Clinical Endocrinology and Metabolism·Richard EastellDolores Shoback
Dec 31, 2020·Journal of the Royal Statistical Society. Series B, Statistical Methodology·Xu ShiEric J Tchetgen Tchetgen

❮ Previous
Next ❯

Citations

Dec 12, 2021·Pharmacoepidemiology and Drug Safety·Sara N LevintowM Alan Brookhart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.